Propanc Health Group Corp.

Common Stock SEC Reporting - Current
Verified Company Profile 3/14/2017
Contact Info
  • 302, 6 Butler Street
  • Camberwell, VIC 3124
  • Australia

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 10-Q
CIK 0001517681
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2007
Employees Not Available
Company Officers/Contacts
James Nathanielsz CEO
Julian Kenyon CSO
James Jenkins Legal Counsel
Company Directors
Not Available
Service Providers
Accounting/Auditing Firm
200 Motor Parkway
Suite B
Hauppauge, NY, 11788
United States
Securities Counsel
Harter Secrest & Emery LLP
1600 Bausch & Lomb Place
Rochester, NY, 14604
United States
Investor Relations Firm
KCSA Strategic Communications
880 3rd Avenue
6th Floor
New York, NY, 10022
United States
Regal Consulting LLC
12533 El Camino Real
Unit E
San Diego, CA, 92130
United States
PPCH Security Details
Share Structure
Market Value1 $8,321,787 a/o Mar 29, 2017
Authorized Shares 2,000,000,000 a/o Sep 26, 2016
Outstanding Shares 914,482,130 a/o Feb 14, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 247,235,602 a/o Oct 21, 2015
Par Value 0.001
Transfer Agent(s)
Corporate Stock Transfer, Inc.
Shareholders of Record 83 a/o Sep 28, 2016
Short Selling Data
Short Interest 3,037 (-97.56%)
Feb 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security